Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
51 Leser
Artikel bewerten:
(0)

Peripheral Vascular Procedure Volumes: Global Analysis, Rapid Growth in Emerging Markets

Medtech and pharmaceutical companies continue to plan and strategize carefully around the large peripheral vascular procedure caseloads in the major US and European markets, however, much attention is being placed on the rapid growth opportunities in other key country markets including China, Russia, India, Mexico, Thailand, Singapore, Malaysia, South Africa, Brazil, and Turkey, amongst others.

LOS ANGELES, May 17, 2017 /PRNewswire/ --Life Science Intelligence (LSI) has announced the release of its Global Peripheral Vascular Surgical Procedure Volumes Database which provides detailed surgical procedure volume data and market forecasts for key peripheral vascular procedures across 32 major countries.

Market Intelligence for Medical Technology Executives

LSI's Global Peripheral Surgical Procedure Volumes Database, an essential tool for medical and pharmaceutical executives focused on peripheral vascular device and drug opportunities, provides the most recent patient and surgical procedure volumes data with detailed 5-year market forecasts. The database provides a single source for strategic planners providing broad geographic and deep procedure level coverage. Consistent research methodologies and definitions are employed for each of the 32 countries and every peripheral vascular procedure covered enabling consistent and reliable comparisons and planning strategies. The database has been developed using extensive primary and secondary research methods, public and private data sources, and dynamic proprietary LSI forecasting models. Data can be accessed and filtered by any combination of country and procedure.

The database includes detailed procedure, patient and market models with current year and 5-year forecasts for key peripheral vascular procedures including:

  • Carotid Artery Thrombectomies
  • Upper Limb Artery Thrombectomies
  • Iliac Artery Thrombectomies
  • Renal Artery Thrombectomies
  • Lower Limb Artery Thrombectomies
  • Carotid Artery Angioplasties
  • Upper Limb Artery Angioplasties
  • Iliac Artery Angioplasties
  • Renal Artery Angioplasties
  • Lower Limb Artery Angioplasties
  • Carotid Artery Bypasses
  • Upper Limb Artery Bypasses
  • Iliac Artery Bypasses
  • Renal Artery Bypasses
  • Aortofemoral and Aortobifemoral Bypasses
  • Femoropopliteal Bypasses
  • Femorotibeal Bypasses
  • Other Lower Limb Bypasses
  • Head, Neck, & Upper Limb Thrombectomies & Thromboendarterectomies
  • Head, Neck, & Upper Limb Angioplasties
  • Removals of the Saphenous Vein
  • Removals of Other Veins of the Lower Limbs

Data is available for each of the following countries:

  • United States
  • Canada
  • Mexico
  • Brazil
  • Russia
  • India
  • China
  • France
  • Italy
  • Germany
  • United Kingdom
  • Spain
  • Australia
  • South Korea
  • Malaysia
  • Singapore
  • Thailand
  • New Zealand
  • Argentina
  • Colombia
  • Chile
  • South Africa
  • Norway
  • Sweden
  • Turkey
  • Poland
  • Switzerland
  • Belgium
  • Netherlands
  • Denmark
  • Finland

For more information visit: http://lsintel.com/surgical-procedure-volumes.php?market=Peripheral%20Vascular

Contact:
Life Science Intelligence
Scott Pantel
714 847 3540 Tel
scott@LSintel.com
www.LSintel.com

Logo - https://mma.prnewswire.com/media/222528/life_science_intelligence_logo.jpg

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.